E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

Investor Relations

DGX (Common Stock)
ExchangeNYSE (US Dollar)
Change (%) Stock is Down 0.72 (0.95%)
Intraday High$75.40
Intraday Low$74.41
Data as of 06/02/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Download Documentation Jefferies 2015 Global Healthcare Conference
Headlines More >
Quest Diagnostics to Speak at the Jefferies 2015 Global Healthcare Conference
MADISON, N.J., May 28, 2015 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies 2015 Global Healthcare Conference in New York.  Steve Rusckowski, the company's President and CEO, will discuss the company's vision, goals and five point strategy.  The presentation is scheduled for Tuesday, June 2, 2015 at 8:00 a.m. Eastern Time. The presentation will be webcast liv... 
Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., May 15, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.38 per share, payable on July 22, 2015 to shareholders of record of Quest Diagnostics common stock on July 8, 2015. About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes.  Derived from the world's largest database of clin... 
Quest Diagnostics to Enhance Quality of Noninvasive Prenatal Screening with QNatal Advanced™
New prenatal screening service provides actionable information for women with high-risk pregnancies MADISON, N.J., May 12, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services and a leader in women's health and genomic testing, today launched QNatal Advanced, a noninvasive prenatal screening service for detecting chromosomal abnormalities in high-risk pregnancies. QNatal Advanced analyzes ... 
Quest Diagnostics Announces LeukoVantage™, Advancing Precision Medicine for Hematologic Malignancies
Genomic service detects 30 gene mutations to aid in the diagnosis, prognosis, monitoring and treatment selection for several myeloid neoplasms MADISON, N.J., May 4, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced LeukoVantage™, an evidence-based genomic test service that aids in the diagnosis, prognosis, monitoring and selection of treatment for myeloid neoplasms, a group of hematologic malignancies that in... 
Upcoming EventsMore >
Quest Diagnostics at Goldman Sachs 36th Annual Global Healthcare Conference
Contact Us:
Dan Haemmerle
Executive Director Investor Relations

Company Calendar
June 2015?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
52 Week High
Formats:  HTML Adobe PDF Word

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.